Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

29 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Plasma and cellular adriamycin concentrations in patients with myeloma treated with ninety-six-hour continuous infusion.
Speth PA, Linssen PC, Holdrinet RS, Haanen C. Speth PA, et al. Among authors: linssen pc. Clin Pharmacol Ther. 1987 Jun;41(6):661-5. doi: 10.1038/clpt.1987.92. Clin Pharmacol Ther. 1987. PMID: 3581649
Plasma and human leukemic cell pharmacokinetics of oral and intravenous 4-demethoxydaunomycin.
Speth PA, van de Loo FA, Linssen PC, Wessels HM, Haanen C. Speth PA, et al. Among authors: linssen pc. Clin Pharmacol Ther. 1986 Dec;40(6):643-9. doi: 10.1038/clpt.1986.239. Clin Pharmacol Ther. 1986. PMID: 3465490
Cellular and plasma pharmacokinetics of weekly 20-mg 4'-epi-adriamycin bolus injection in patients with advanced breast carcinoma.
Speth PA, Linssen PC, Beex LV, Boezeman JB, Haanen C. Speth PA, et al. Among authors: linssen pc. Cancer Chemother Pharmacol. 1986;18(1):78-82. doi: 10.1007/BF00253070. Cancer Chemother Pharmacol. 1986. PMID: 3463436
Cellular and plasma adriamycin concentrations in long-term infusion therapy of leukemia patients.
Speth PA, Linssen PC, Boezeman JB, Wessels HM, Haanen C. Speth PA, et al. Among authors: linssen pc. Cancer Chemother Pharmacol. 1987;20(4):305-10. doi: 10.1007/BF00262581. Cancer Chemother Pharmacol. 1987. PMID: 3480081
Leukemic cell and plasma daunomycin concentrations after bolus injection and 72 h infusion.
Speth PA, Linssen PC, Boezeman JB, Wessels HM, Haanen C. Speth PA, et al. Among authors: linssen pc. Cancer Chemother Pharmacol. 1987;20(4):311-5. doi: 10.1007/BF00262582. Cancer Chemother Pharmacol. 1987. PMID: 3690804
In vivo cellular adriamycin concentrations related to growth inhibition of normal and leukemic human bone marrow cells.
Speth PA, Raijmakers RA, Boezeman JB, Linssen PC, de Witte TJ, Wessels HM, Haanen C. Speth PA, et al. Among authors: linssen pc. Eur J Cancer Clin Oncol. 1988 Apr;24(4):667-74. doi: 10.1016/0277-5379(88)90297-0. Eur J Cancer Clin Oncol. 1988. PMID: 3383969
Infusion-rate independent cellular adriamycin concentrations and cytotoxicity to human bone marrow clonogenic cells (CFU-GM).
Raijmakers R, Speth P, de Witte T, Linssen P, Wessels J, Haanen C. Raijmakers R, et al. Br J Cancer. 1987 Aug;56(2):123-6. doi: 10.1038/bjc.1987.168. Br J Cancer. 1987. PMID: 3663464 Free PMC article.
In vivo and in vitro pharmacokinetic differences between four structurally closely related anthracyclines in hematopoietic cell subtypes in humans.
Speth PA, Linssen PC, Termond EF, Boezeman JB, Wessels HM, Haanen C. Speth PA, et al. Among authors: linssen pc. Drug Metab Dispos. 1989 Jan-Feb;17(1):98-105. Drug Metab Dispos. 1989. PMID: 2566478
Quantitation of anthracyclines in human hematopoietic cell subpopulations by flow cytometry correlated with high pressure liquid chromatography.
Speth PA, Linssen PC, Boezeman JB, Wessels HM, Haanen C. Speth PA, et al. Among authors: linssen pc. Cytometry. 1985 Mar;6(2):143-50. doi: 10.1002/cyto.990060210. Cytometry. 1985. PMID: 3856510
Chemokine induction by all-trans retinoic acid and arsenic trioxide in acute promyelocytic leukemia: triggering the differentiation syndrome.
Luesink M, Pennings JL, Wissink WM, Linssen PC, Muus P, Pfundt R, de Witte TJ, van der Reijden BA, Jansen JH. Luesink M, et al. Among authors: linssen pc. Blood. 2009 Dec 24;114(27):5512-21. doi: 10.1182/blood-2009-02-204834. Epub 2009 Oct 14. Blood. 2009. PMID: 19828696
29 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback